Unknown

Dataset Information

0

Endosomal trafficking inhibitor EGA can control TLR7-mediated IFNα expression by human plasmacytoid dendritic cells.


ABSTRACT: Plasmacytoid dendritic cells (pDC) are the major producer of type 1 IFN in response to TLR7 agonists. Aberrant TLR7 activation and type 1 IFN expression by pDCs are linked to the pathogenesis of certain types of autoimmune diseases, including systemic lupus erythematosus (SLE). This study investigated the underlying mechanisms for TLR7-mediated cytokine expression by pDCs using a late endosome trafficking inhibitor, EGA (4-bromobenzaldehyde N-(2,6-dimethylphenyl) semicarbazone). We found that EGA treatment decreased IFNα expression by pDCs stimulated with imiquimod (R837), single-stranded RNA40, and influenza virus. EGA also decreased TNFα expression and secretion by R837-stimulated pDCs. Mechanistically, EGA treatment decreased phosphorylation of IKKα/β, STAT1, and p38, and prolonged degradation of IκBα. Furthermore, EGA treatment decreased the colocalization of 3F, a substituted adenine TLR7 agonist, with LAMP1+ compartments in pDCs. EGA was also capable of diminishing IFNα expression by SLE pDCs treated with R837 or live PR8/A/34 influenza viruses. Therefore, we concluded that trafficking of TLR7 agonists to LAMP1+ compartments is important for IFNα expression by pDCs. Data from this study support additional examinations of the potential benefits of EGA in treating type 1 IFN-associated inflammatory diseases in the future.

SUBMITTER: Wiest MJ 

PROVIDER: S-EPMC10704457 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature

altmetric image

Publications

Endosomal trafficking inhibitor EGA can control TLR7-mediated IFNα expression by human plasmacytoid dendritic cells.

Wiest Matthew J MJ   Baert Laurie L   Gu Chao C   Gayler Kevin M KM   Ham Hyoungjun H   Gorvel Laurent L   Keddis Mira T MT   Griffing Leroy W LW   Joo HyeMee H   Gorvel Jean-Pierre JP   Billadeau Daniel D DD   Kane Robert R RR   Oh SangKon S  

Frontiers in immunology 20231124


Plasmacytoid dendritic cells (pDC) are the major producer of type 1 IFN in response to TLR7 agonists. Aberrant TLR7 activation and type 1 IFN expression by pDCs are linked to the pathogenesis of certain types of autoimmune diseases, including systemic lupus erythematosus (SLE). This study investigated the underlying mechanisms for TLR7-mediated cytokine expression by pDCs using a late endosome trafficking inhibitor, EGA (4-bromobenzaldehyde <i>N</i>-(2,6-dimethylphenyl) semicarbazone). We found  ...[more]

Similar Datasets

| S-EPMC10067882 | biostudies-literature
| S-EPMC4830934 | biostudies-literature
| S-EPMC6121190 | biostudies-literature
| S-EPMC8117785 | biostudies-literature
| S-EPMC7243911 | biostudies-literature
| S-EPMC3723633 | biostudies-literature
| S-EPMC11254756 | biostudies-literature
| S-SCDT-EMBOJ-2021-109622 | biostudies-other
| S-EPMC5640662 | biostudies-literature
| S-EPMC6687199 | biostudies-literature